Clinical Trial Update: Methylphenidate to Improve Balance and Walking in MS [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update reports results evaluating methylphenidate to improve balance and walking in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-04-05